home / stock / axsm / axsm articles

AXSM Articles, Axsome Therapeutics Inc.

Stock Information
Company Name: Axsome Therapeutics Inc.
Stock Symbol: AXSM
Market: NASDAQ
Website: axsome.com
Menu
AXSM AXSM Quote AXSM Short AXSM News AXSM Articles AXSM Message Board
Get AXSM Alerts

News, Short Squeeze, Breakout and More Instantly...
Wall Street Analysts Predict a 49.36% Upside in Axsome: Here's What You Should Know | Benzinga

Axsome Therapeutics (NASDAQ: AXSM) closed the last trading session at $83.74, gaining 10.2% over the past four weeks, but there could be plenty of ...
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories | Benzinga

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM) (Axsome), a biopharmaceutical company developing and deliver...

Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month | Benzinga

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel...

Axsome Therapeutics Supports Alzheimer's & Brain Awareness Month | Benzinga

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel...
Axsome Therapeutics to Participate in Upcoming Investor Conferences | Benzinga

NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel ...

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024 | Benzinga

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel ...

Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting | Benzinga

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel ...
Hello Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session | Benzinga

U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining around 0.5% on Tuesday. Shares of Hello Group Inc. (NASDAQ:MOMO...

Axsome Therapeutics Recognizes May as Mental Health Awareness Month | Benzinga

NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel ...

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting | Benzinga

AXS-05 in Alzheimer's disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in poole...
Next 10